Max Healthcare Institute Limited will host an earnings call for investors and analysts on Friday, August 14, 2026, at 11:00 AM IST to discuss its financial performance for the first quarter of fiscal year 2027 (Q1FY27). The company aims to provide clarity on its operational and financial outcomes for the quarter ended June 30, 2026, allowing stakeholders to assess the healthcare provider's progress amid broader market conditions.

The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Max Healthcare has notified both the National Stock Exchange of India Limited and BSE Limited regarding the schedule. The financial results for the period are set to be formally declared on Thursday, August 13, 2026, one day prior to the interactive session.

Earnings Call Details

The conference call will feature a brief management discussion followed by an interactive Question & Answer session. Senior members of the management team will be present to address queries from investors and analysts. Participants can join the call via pre-registration through DiamondPass™ to ensure zero wait time.

International participants can access the call via toll-free numbers provided for Hong Kong, Singapore, the UK, and the USA. The full details of the conference call, including dial-in codes, are available on the company’s website at www.maxhealthcare.in .

Operational Context

Max Healthcare Institute Limited operates as one of India’s largest healthcare organizations, committed to clinical excellence and patient care. The network comprises 21 healthcare facilities with over 6,100 beds, primarily concentrated in North India. Key locations include multiple hospitals in Delhi NCR (Saket, Patparganj, Vaishali, Rajendra Place, Dwarka, Noida, and Shalimar Bagh), along with facilities in Lucknow, Mumbai, Nagpur, Mohali, Bathinda, Dehradun, and Bhubaneswar.

In addition to its hospital network, the company operates homecare services under the brand Max@Home and diagnostic services under Max Labs. The hospitals in Mohali and Bathinda operate under Public-Private Partnership (PPP) arrangements with the Government of Punjab. This diversified infrastructure supports the company’s service delivery model across tertiary, quaternary, and secondary care segments.

Forward-Looking Statements

The company issued a safe harbor disclaimer noting that statements made during the call may include forward-looking statements regarding strategic initiatives and future business developments. These projections are subject to risks such as macroeconomic trends, regulatory changes, competitive pressures, and public health events like pandemics. Investors are advised that actual results may differ materially from these expectations.

Furthermore, the financial information presented during the call includes data from network and partner facilities, which may not meet statutory audit requirements applicable to standalone audited financials. The call is intended for general informational purposes only.

The National Company Law Tribunal (NCLT), Cuttack Bench, has permitted the rectification of a procedural defect in ongoing legal proceedings involving max healthcare institute and its subsidiary, Kalinga Hospital Ltd (KHL). The tribunal’s order, received by the company on August 7, 2026, allows the opposing party to file an additional affidavit to correct an error in a Postal Ballot Notice annexed to their interlocutory petition. This development ensures the continuation of the case, which centers on petitions filed by the legal representatives of BRS Capital Two Pte. Limited against KHL, the other shareholder from whom Max Healthcare acquired a majority equity stake, and the company itself. The next hearing is scheduled for August 19, 2026.

Procedural Developments

The matter was heard on August 4, 2026, at 10:30 am IST. During the hearing, Max Healthcare Institute Ltd and other respondents raised objections regarding the maintainability of the interlocutory petition. The core objection cited an incorrect Postal Ballot Notice attached to the application filed by the legal representatives of BRS Capital Two Pte. Limited.

The NCLT observed that the identified defect was procedural in nature. In the interest of justice and consistent with the principles of natural justice, the tribunal permitted the opposite party to rectify the defect by filing an additional affidavit. Consequently, the interlocutory petition will be heard alongside the main Company Petition at the next scheduled date.

Timeline of Proceedings

Regulatory Disclosure

This disclosure is made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that there is no change in the status of any settlement, as no settlement has occurred. The litigation does not involve key management personnel, promoters, or the ultimate person in control in a manner requiring specific disclosure under those categories. The full details are hosted on the company’s website.

What the Numbers Show

While no financial figures are disclosed in this specific regulatory filing, the continuation of litigation with BRS Capital Two Pte. Limited represents a potential contingent liability for Max Healthcare Institute Ltd. The outcome of the main Company Petition, now proceeding alongside the rectified interlocutory petition, could impact the company’s financial position or strategic control over Kalinga Hospital Ltd. Investors should monitor subsequent filings for updates on the final adjudication of the main petition.